Literature DB >> 8168944

Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

T Kelly1, J P Dillard, J Yother.   

Abstract

To assess the role of capsular serotypes in the virulence of Streptococcus pneumoniae, we have constructed isogenic derivatives differing only in the type of capsule expressed. Strains of types 2, 5, and 6B were converted to type 3 by transformation and selection for an erythromycin resistance marker linked to the type 3 capsule locus. Characterization studies revealed that these type 3 derivatives were indistinguishable from the type 2, type 5, and type 6B parental strains in terms of restriction enzyme fragment pattern and expression of pneumococcal surface protein A (PspA). Expression of the type 3 capsule did not alter the mouse virulence of the similarly virulent type 2 strain. However, alteration of capsule type had a profound effect on the virulence of the type 5 and type 6B derivatives. The highly virulent type 5 strain was essentially avirulent when expressing the type 3 capsule. Conversely, the 50% lethal dose of the relatively avirulent type 6B strain was reduced > 100-fold when the type 3 capsule was expressed. Thus, the serotype of capsule expressed has a major effect on virulence, and this effect is dependent upon the genetic background of the recipient strain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168944      PMCID: PMC186414          DOI: 10.1128/iai.62.5.1813-1819.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.

Authors:  L S McDaniel; J S Sheffield; E Swiatlo; J Yother; M J Crain; D E Briles
Journal:  Microb Pathog       Date:  1992-10       Impact factor: 3.738

4.  Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.

Authors:  J Yother; G L Handsome; D E Briles
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

5.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

6.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

7.  Growth characteristics of group A streptococci in a new chemically defined medium.

Authors:  I van de Rijn; R E Kessler
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

8.  Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.

Authors:  J A Winkelstein; A S Abramovitz; A Tomasz
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

9.  Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974.

Authors:  M Finland; M W Barnes
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

10.  Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide.

Authors:  J C Knecht; G Schiffman; R Austrian
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy.

Authors:  Paola Stefanelli; Cecilia Fazio; Arianna Neri; Tonino Sofia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Contribution of a response regulator to the virulence of Streptococcus pneumoniae is strain dependent.

Authors:  Clare E Blue; Tim J Mitchell
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors:  Melanie Abeyta; Gail G Hardy; Janet Yother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome.

Authors:  N Luisa Hiller; Benjamin Janto; Justin S Hogg; Robert Boissy; Susan Yu; Evan Powell; Randy Keefe; Nathan E Ehrlich; Kai Shen; Jay Hayes; Karen Barbadora; William Klimke; Dmitry Dernovoy; Tatiana Tatusova; Julian Parkhill; Stephen D Bentley; J Christopher Post; Garth D Ehrlich; Fen Z Hu
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

7.  Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine.

Authors:  Damien M O'halloran; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.

Authors:  Isabelle Henckaerts; David Goldblatt; Lindsey Ashton; Jan Poolman
Journal:  Clin Vaccine Immunol       Date:  2006-03

9.  Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

Authors:  Y Mizrachi-Nebenzahl; S Lifshitz; R Teitelbaum; S Novick; A Levi; D Benharroch; E Ling; R Dagan
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.